The Clinical Significance of CT-based Biomarkers in the Classification and Prognosis of Bronchiectasis
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
300 participants
Mar 30, 2024
OBSERVATIONAL
Conditions
Summary
As the third major chronic airway disease in China, bronchiectasis has a wide range of patients. However, the involved sites, morphological features and airway obstruction of bronchiectasis are varied, and clinical heterogeneity is high, making prognosis and severity difficult to evaluate. CT plays an important role in the diagnosis and classification of ramadasis. Based on this, we analyzed the CT findings of patients with bronchiectasis and followed up patients with bronchiectasis to understand their disease progression and prognosis, so as to further analyze the role of CT biomarkers in the type and prognosis of bronchiectasis diseases.
Eligibility
Inclusion Criteria4
- Age 18 years and above;
- Can cooperate with CT scan;
- Bronchiectasis confirmed by high-resolution computed tomography of the lungs;
- Can provide written informed consent
Exclusion Criteria5
- Pulmonary surgery;
- Patients with lung cancer, asthma and other respiratory diseases;
- Tractive bronchiectasis caused by pulmonary fibrosis;
- Patients with malignant tumors or serious dysfunction of the heart, brain, kidney and other important systems can not cooperate with the completion of this study；
- Lack of important clinical information.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06346938